Beta
391929

Exercise and/or Liposomal Curcumin Modulates Sarcolipin/ Sarcoplasmic reticulum Ca2+-ATPase pump to Counteract Fibrillin/Asprosin/OLFR734 Pathway in Obese Diabetic Rats

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

Muscle Physiology

Abstract

Background: Predominance of adiposity and diabetes is dramatically expanding. Asprosin, a novel adipokine, serve as cross-organ messenger, linking adipose tissue with skeletal muscle. Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump mediates Ca2+ entry from sarcoplasm back to its lumen. Sarcolipin (SLN) is an uncoupler of SERCA pump, playing an important role in muscle-based thermogenesis. Aim: We aimed to explore the role of exercise (EX) and/or liposomal curcumin (LP-CUR) to counteract asprosin in the pathogenesis of adiposity by modulating the SLN/SERCA proteins. Materials and method: This study was conducted for 8 weeks through 5 Groups of rats. The control group fed normal diet. While, the others were fed high-fat diet (HFD) either alone HFD group, or with performing EX by running on treadmill at 20 m/min for 1 hour/day, 4 days/week, or received LP-CUR 10 mg/kg/day, or combination of both. Results: The HFD group exhibited significant dyslipidemia, hyperglycemia, insulin resistance, oxidative and sarcoplasmic reticulum stress, rise in body weight gain %, fat pad mass, and decline in lean body mass with reduced physical endurance versus the control group. The asprosin at both mRNA and protein levels were predominantly overexpressed in the HFD group. Fortunately, EX training and/or LP-CUR administration prevented such HFD bad consequences. They caused overexpression of soleus SLN and SERCA proteins, mitochondrial biogenesis, and increased enzymes activities responsible for oxidative metabolism. The core temperature and time to exhaustion were also increased. Conclusion: Our study suggests EX and/or LP-CUR enhanced thermogenesis as an effective strategy to counteract obesity and related comorbidities.

DOI

10.21608/besps.2024.331239.1184

Keywords

FBN1/asprosin/OLFR734, Sarcolipin/SERCA, Liposomal Curcumin, Endoplasmic reticulum stress, muscle-based thermogenesis

Authors

First Name

Marwa

Last Name

Muhammad

MiddleName

Hassan

Affiliation

Physiology Department, Faculty of Medicine, Benha University, Egypt.

Email

marwa.moslem@fmed.bu.edu.eg

City

-

Orcid

0000-0002-7372-2560

First Name

Sherine

Last Name

Elsharkawy

MiddleName

M.

Affiliation

Physiology Department, Faculty of Medicine, Benha University, Egypt.

Email

sherinesharkawy1981@gmail.com

City

Benha

Orcid

0009-0003-8197-2134

First Name

Abeer

Last Name

Abd Elhameed

MiddleName

-

Affiliation

Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine, Benha University, Benha, Egypt.

Email

abeer.attia@fmed.bu.edu.eg

City

-

Orcid

-

First Name

Esraa

Last Name

Khairat

MiddleName

-

Affiliation

Department of Histology, Faculty of Medicine, Benha University, Benha 13518, Egypt

Email

esraa.hammad@fmed.bu.edu.eg

City

-

Orcid

-

First Name

Nashwa

Last Name

Ahmed

MiddleName

-

Affiliation

Department of Medical Biochemistry and molecular biology, Faculty of Medicine, Benha University, Benha city,13518 Egypt.

Email

nashwa.mohamed@fmed.bu.edu.eg

City

-

Orcid

-

First Name

Reham

Last Name

Ibrahim

MiddleName

Mohammed

Affiliation

Physiology Department, Faculty of Medicine, Benha University, Egypt.

Email

reham.mohamed@fmed.bu.edu.eg

City

-

Orcid

-

Related Issue

-2

Receive Date

2024-10-26

Publish Date

2024-11-14

Page Start

51

Page End

76

Print ISSN

1110-0842

Online ISSN

2356-9514

Link

https://besps.journals.ekb.eg/article_391929.html

Detail API

https://besps.journals.ekb.eg/service?article_code=391929

Order

391,929

Type

Original Article

Type Code

567

Publication Type

Journal

Publication Title

Bulletin of Egyptian Society for Physiological Sciences

Publication Link

https://besps.journals.ekb.eg/

MainTitle

Exercise and/or Liposomal Curcumin Modulates Sarcolipin/ Sarcoplasmic reticulum Ca2+-ATPase pump to Counteract Fibrillin/Asprosin/OLFR734 Pathway in Obese Diabetic Rats

Details

Type

Article

Created At

24 Dec 2024